Other

Finite-Lived Intangible Assets, Accumulated Amortization

Vertex Pharmaceuticals Finite-Lived Intangible Assets, Accumulated Amortization increased by 12.4% to $51.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 78.0%, from $29.10M to $51.80M. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ4 2024
Last reportedQ1 2026May 5, 2026

How to read this metric

A rising balance relative to gross assets indicates an aging portfolio of intangible assets nearing the end of their useful lives.

Detailed definition

The cumulative amount of amortization expense recognized against finite-lived intangible assets since their acquisition...

Peer comparison

Standard accounting metric; peers with older acquisition cycles will show higher accumulated amortization relative to gross assets.

Metric ID: other_finite_lived_intangible_assets_accumulated_amortization

Historical Data

6 periods
 Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$23.40M$29.10M$34.80M$40.50M$46.10M$51.80M
QoQ Change+24.4%+19.6%+16.4%+13.8%+12.4%
YoY Change+97.0%+78.0%
Range$23.40M$51.80M
CAGR+88.8%
Avg YoY Growth+87.5%
Median YoY Growth+87.5%
Current Streak5+ quarters growth

Finite-Lived Intangible Assets, Accumulated Amortization at Other Companies

Frequently Asked Questions

What is Vertex Pharmaceuticals's finite-lived intangible assets, accumulated amortization?
Vertex Pharmaceuticals (VRTX) reported finite-lived intangible assets, accumulated amortization of $51.80M in Q1 2026.
How has Vertex Pharmaceuticals's finite-lived intangible assets, accumulated amortization changed year-over-year?
Vertex Pharmaceuticals's finite-lived intangible assets, accumulated amortization increased by 78.0% year-over-year, from $29.10M to $51.80M.
What does finite-lived intangible assets, accumulated amortization mean?
The total amount of value written off from intangible assets over their useful lives.